Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 1c

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results

November 2, 2023 4:05 PM EDT

Company to present new data at AASLD from Phase 2 chronic hepatitis B and chronic hepatitis delta clinical trials

Company expanding strategic focus to autoimmune diseases and immuno-oncology

Jennifer Towne, Ph.D., appointed as Executive Vice President and Chief Scientific Officer, effective November 6, 2023

Secured new BARDA funding for the development of RNA-delivered monoclonal antibodies

$1.7 billion in cash, cash equivalents and investments as of September 30, 2023

Conference call scheduled for 1:30 p.m. PT / 4:30 p.m. ET, November 2, 2023

SAN FRANCISCO--(BUSINESS WIRE)-- Vir... More